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Background: In most developed countries there is an increasing ageing population living in the com-
munity with long-term conditions and sensory impairment (sight; hearing; dual impairment). Com-
munity pharmacy personnel are key providers of pharmaceutical care to this patient population.
Objective: This study explored community pharmacy personnel's experiences with providing pharma-
ceutical care for older people with sensory impairment.
Methods: Semi-structured telephone interviews were conducted with community pharmacy personnel
across Scotland between 2015 and 2016.
Results: Thirty interviews were completed with community pharmacists (n¼ 17) and other pharmacy
personnel (n¼ 13). Two overarching themes emerged: safety and communication. Interviewees reported
patients' reluctance to disclose their impairment “patients are very good at hiding it” and had considerable
safety concerns “it's a fear that they're going to take toomuch… accidentally taking the samemedicine twice”.
Difﬁculties in communicationwere cited “no matter what you do or how you label things, leaﬂets and telling
people, things can gowrong”. Additionally, interviewees identiﬁed training needs to increase their disability
awareness and to identify strategies to provide safe and reliable pharmaceutical care to this vulnerable
group “We don't speciﬁcally have anything in place to deal with anyone with impairments of that kind”.
Conclusions: This is the ﬁrst in-depth exploration of providing pharmaceutical care to older people with
sensory impairment from the perspective of community pharmacy personnel. Strategies are needed to
encourage older people to disclose their sensory impairment. Education and training are also needed to
optimise the provision of pharmaceutical care to this vulnerable population.
© 2018 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).epartment of Pharmacy and
7AY, UK.
usein), k.killick@napier.ac.uk
n), annetta.smith@uhi.ac.uk
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ath.ac.uk (M.C. Watson).
r Inc. This is an open access articleSight and hearing impairment (hereafter referred to as sensory
impairment) are signiﬁcant global health concerns and are the
most common conditions associated with ageing. Sight loss and
age-related eye conditions are a major cause of disability world-
wide.1 Age-related hearing loss affects approximately one third of
people aged 65 years.2 Sight or hearing impairment is associated
with higher mortality and mortality is higher with dual compared
with single impairment i.e. visual and hearing impairments.3under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
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is also reﬂected in an increased number of medicines taken, known
as polypharmacy if four medicines or more are used.4 The Health
Survey for England (2013)5 reported that more than half of those
aged65 years were using at least three medicines, and more than
a third of those aged 75 years were taking at least six medicines,
thus increasing the risk of adverse effects and drug interactions.
Demographic and functional characteristics e.g. male gender,
cognitive or sensory impairment, are associated with greater
medicine management needs and challenges among the older
population.6e12 Community dwelling older adults are at higher risk
of adverse drug reactions (ADRs) and hospital admission.13 Theses
risks are exacerbated by inappropriate prescribing and monitoring
of medications and polypharmacy.14,15
Older people with sensory impairment have reduced ability to
manage medications and to achieve medication adherence
compared with older people without sensory impairment,16,17
While there is a growing body of literature that focuses on medi-
cine management of older people, most of this work has focused on
nursing home residents.18e20 A recent scoping review revealed a
paucity of research in this area.21
Pharmacists are increasingly involved in medication review to
improve the pharmacotherapy of older patients.22e25 The Sensory
impairment and Pharmaceutical Care study26 was a research pro-
grammewhich explored the pharmaceutical care needs of older peo-
ple with sensory impairment and the study presented here explored
the perspectives of community pharmacy personnel regarding the
provision of pharmaceutical care to this patient population.
Methods
For this element of the study, semi-structured, telephone in-
terviews were undertaken with community pharmacy personnel
between 2015 and 2016. The interviews aimed to explore com-
munity pharmacy personnel’ experienceswith pharmaceutical care
provision to older people with sensory impairments.
Interviewees, sampling and recruitment
Community pharmacy personnel (pharmacists and pharmacy
support staff) were recruited across Scotland. Individuals who were
members of the community pharmacy team and working in a com-
munity pharmacy in Scotland were eligible to participate. Commu-
nity Pharmacy Scotland (CPS),27 the Scottish national contractor
organization, supported recruitment on behalf of the project team.
Recruitment of pharmacy personnel was guided by theoretical
sampling28 following interviews with older people with sensory
impairments that identiﬁed pharmaceutical care needs being partly
dependent on the size and location of pharmacies. Pharmacies were
then purposively recruited through Community Pharmacy Scotland,
stratiﬁed by geographical variation (urban and rural) and pharmacy
organisational type (independent, small chain, large multiple). The
purpose of this was to achieve a maximum variation sample. In-
terviewees were contacted by email or telephone. Pharmacist re-
spondents who expressed an interest in participating in the study
werealso requested tonominateanothernon-pharmacistmemberof
their pharmacy team to participate. Interviewswere conducted until
data saturation was deemed to have been reached i.e. no new infor-
mation relating to the topics of interest were obtained. Preliminary
data analysis conﬁrmed this to be the case.29,30
Procedure for data collection
All interviewees received a study information pack and a sum-
mary of the interview topic guide prior to the interview date.Interviewees were required to complete and return their written
consent form prior to the interview. The semi-structured topic
guide (Appendix A) was developed by the research team in
consultation with the Project Advisory Group. The topics explored
included: the participant's role in the pharmaceutical care for older
people with sensory impairments; barriers and facilitators to
providing pharmaceutical care; perceived risks to patients; and,
participants' perceptions of relevant training. Pilot interviews were
conducted and since no changes were suggested, pilot data were
included in the ﬁnal analysis. Interviews were conducted by (KK), a
post-doctoral female health psychologist researcher, PhD.
Data management and analysis
All interviews were digitally recorded, transcribed verbatim and
converted to anonymized word ﬁles. Transcripts were coded using
NVivo (version 11) and analysed thematically.31,32 Theprocessﬁrstly
used open coding which was followed by axial coding; categories
and subcategories were identiﬁed and arranged conceptually in a
hierarchy. Integrative memos were developed that linked the sub-
categories to each category to interpret the data.33 Two researchers
(NA, AT) read all the interview transcripts and independently
double-coded the ﬁrst ﬁve to assess consistency of coding. Varia-
tions in codingwere reviewed, discussed and agreed (NA, AT).34 The
coding framework evolved inductively and iteratively from the data
through this process. Detailed codes and theme descriptions were
produced (NA, AT), and checkedandﬁnalised byNA, AT,MW, LMand
AS (Appendix B). Due to the high levels of agreement achieved using
thisprocess, the remaining transcriptswerecodedbyone researcher
(NA). Illustrative quotes are presented with descriptors including
anonymised health board (e.g. HB-A, HB-B) to protect the conﬁ-
dentiality of the interviewees (Health board is a term used in Scot-
land to describe a geographical area with relation to the delivery of
health services in that area). Triangulation of these data is reported
elsewhere using data from service user interviews and a national
survey of community pharmacists.35
Formal ethical review approval was received from the University
of Dundee Research Ethics Committee (January 2016: Ethics Review
reference number 15187). NHS ethical approval was not required.
Results
Thesamplewasdiversewith respect todifferent typesofpharmacy
personnel. Thirty interviewswere completed comprising pharmacists
(n¼ 17), pre-registration pharmacists (n¼ 5), medicine counter as-
sistants (n¼ 4), trainee pharmacy technicians (n¼ 2), dispensers
(n¼ 1), and a pharmacy retail manager (n¼ 1). Just over half the in-
terviewees (17) worked in independent, single outlet pharmacies
(Table1). Data saturationwas achievedwithnonewthemes emerging
in the later interviews.29,30 The interviews lasted up to 27min.
Four themes emerged from the analyses: two overarching inter-
related themes, safety and communication; and two additional
themes: factors affecting the provision of pharmaceutical care to this
patient population (Fig.1); and, solutions. Safetyand communication
concerns permeated all aspects of pharmaceutical care discussed.
Safety
Perceived failure to provide suitable pharmaceutical care caused
community pharmacy personnel concerns about patient safety.
Interviewees were concerned about patient safety at all stages of
the pharmaceutical care journey i.e. from the ordering of medicines
to their storage and administration.
Several interviewees raised concerns and safety issues about the
use of multi-compartment compliance aids i.e. devices divided into
Table 1
Demographic characteristics of Community pharmacy personnel interviewees.
Role (total number interviewed) Number of years in
practice (mean± SD)
Pharmacy ownership
(number interviewed)
Health board (number of participants
interviewed)
Pharmacist (17) 21± 10.5 Independent (11), Large
multiple (3), Others (3)
Grampian (3), Tayside (5), Highlands &
Islands (2), Edinburgh & Lothian (2), Others
(5)
Pre-registration pharmacist (5) <1 Large multiple (5) Edinburgh & Lothian (2), Others (5)
Other community pharmacy personnel: medicines counter assistant (4),
trainee technician (2), dispenser (n¼ 1), pharmacy retail manager (n¼ 1)
9± 8 Independent (6), Small
chain (2)
Grampian (3), Tayside (3), Others (2)
Others: when the number is one, data were combined to avoid the risk of identiﬁcation.
Fig. 1. Factors affecting the provision of pharmaceutical care to older people with
sensory impairment from the perspective of Community pharmacy personnel.
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problems included: the small font size on the dosage form; the risk
of overdose when switching to use these systems; dropping tablets
due to packaging access problems; losing independence; and side
effects due to a concurrent administration of several medicines
(Table 2). One participant suggested doing home visits to provide
explanation about the devices and follow-up visits to patients
beneﬁting from delivery service or the multi-compartment
compliance aids service.Table 2
Perceived risks related to multi-compartment compliance aids for older people with sen
Small Print “so the [multi-compartment complia
teatime, bedtime, and this gentleman
sight he just kept going down the lin
Danger of overdose when starting a multi-
compartment compliance aids
“There is the other option of us puttin
ﬁnd patients will start on the bubble
and we'd put them in the right times
They're hospitalized … It does expose
Dropping medicine form the multi-compartment
compliance aids
“For example, I remember an elderly l
them out and they fall on the ﬂoor I c
them up, I'm 94” (ID21, pharmacist,
Losing independence and conﬁdence “It can become quite messy. I just thin
not necessarily the safest way to go”
Side effects “So, there's one medication has to be t
She was having all sorts of gastro-int
Can't distinguish between the tablets “if you made it up with a patient pack
then that they've got problems over w
Pressure on the pharmacy “We are a small pharmacy; we do abo
at the moment” (ID14, pharmacist, i“so if it's a new one [multi-compartment compliance aid] I would
go out to the house and we explain it [how to use the multi-
compartment compliance aids] to them [patients] ﬁrst, and you
know how to take their medicine, and how they get into the pack,
and exactly what is going to happen” (ID8, Trainee Technician,
Independent, HB-H)
Most interviewees acknowledged that patients with sight
impairment rely on the texture, shape, size, and colour of the tab-
lets and their boxes to identify medicines. Several interviewees
reported using extra identiﬁcation marks to help their patients, for
example coloured stickers, rubber bands, different box sizes. Many
interviewees also reported that pharmaceutical companies
frequently change a medicine's brand image and this added to the
complexities that these patients experience in managing their
medicines.
“We havemedications out there that one day it'll come in a box that
size, and from another manufacturer it'll be in a box that size. They
go from big, white round things, to little pink triangular shape
things, and that's a problem” (ID12, Pharmacist, independent,
HB-H).
Several adverse incidents were reported by the interviewees.
“I told him to take eight tablets, all at once, every day for ﬁve days.
His carer was with him who also repeated it, then he went away
home and had [took] it all at once and took them all… because all
he heard was all at once” (ID24, Pharmacist, HB-I)
Other concerns included the risk of using narrow therapeutic
index medicines, where there is only a small difference between
the minimum effective concentrations and the minimum toxicsory impairment.
nce aids] is Monday, Tuesday, Wednesday, Thursday, Friday, morning, lunchtime,
had taken morning, morning, morning, morning … but with a little bit of impaired
e” (ID12, pharmacist, independent, HB-H)
g them into the bubble packs [multi-compartment compliance aids] and you'll often
pack [multi-compartment compliance aids] who weren't taking them properly before
and they'd start taking them at the right times … and then they're overprescribed.
a big problem in some cases” (ID17, pharmacist, small chain, HB-B)
ady who was in her 90swho had some form of visual impairment… She said yes, I pop
an't ﬁnd them because I can't see. Even if I could see them I couldn't bend down to pick
independent, HB-D)
k it removes the independence and thinking behind the medicines and actually that is
(ID22, pharmacist, independent, HB-F)
aken on its own and tends not to go in a tray, but the GP had insisted it went in the tray.
estinal problems” (ID12, pharmacist, independent, HB-H)
, if for example a doctor stops then one of the medications, if they've not good sight, it's
hich tablet they actually take out” (ID25, pharmacist, independent, HB-C)
ut 4000 [prescription items] per month. But I have between 65 and 75 patients on trays
ndependent, HB-F)
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population.
“If they are on… an anticoagulant or something you would need to
communicate with them what to look out for, extra bleeding and
things like that; depends if they would understand that, depends if
you get that across to them” (ID3, Pre-registration Pharmacist,
Small chain, HB-A)Communication
Ineffective communication between community pharmacy
personnel and older patients with sensory impairment was re-
ported to inﬂuence the quality of the pharmaceutical care journey.
For example, some patients with hearing impairment were
perceived to nod and indicate that they heard the pharmacist while
actually having heard only part of the instructions. Additional
concerns regarding hearing impairment included: provision of in-
formation to patients; inability to test the understanding of pa-
tients; not understanding the patient's needs; not using hearing
loops; and difﬁculties with telephone communication.
“you do get halfway through a consultation and you realise that
someone's … smiling and not saying anything …” (ID30, pre-
registration pharmacist, multiple chain)
Some interviewees reported speaking louder and gesturing with
people with hearing impairment. Others reported writing in-
structions, giving readingmaterial or lip reading. Sign languagewas
used when a member of staff had this expertise. Some interviewees
reported using images and videos from the internet, text messages,
and emails as communication aids. However, several interviewees
noted that not all patients use sign language and written infor-
mation might be complex for deaf people.
“She has no hearing, she lip-reads and signs, and it wasn't until
maybe ﬁve or ten minutes of trying to understand what was wrong
with her, that I realised one of the girls who works in the shop
actually does have sign language, and from that within a minute
we were able to ﬁnd out what was wrong” (ID11, Pharmacist,
Independent, HB-H)
“Does Mr so and so read, does he write? If I wrote something down
would that help? … So if he is a ‘signer’ [uses sign language] and
has never learned the English language as such, then maybe I've
been doing it wrong.” (ID17, Pharmacist, Small chain, HB-B)
For older patients with sight impairment, concerns were raised
relating to their ability to read patient information sheets and la-
bels. Using large print, Braille and giving verbal instructions were
examples of information provision or communicating with people
with varying degrees of sight impairment. Whilst large print was
popular between the interviewees, several limitations were high-
lighted and included the extent to which it could actually help, and
how much information could be printed in large font. Whilst the
provision of verbal instructions was suggested as a solution to these
difﬁculties, interviewees were concerned that patients who were
receiving polypharmacy and/or with memory loss would be unable
to retain all the relevant information. One interviewee suggested
that speaking labels might help.
I would say none of my visual impaired people could read Braille
because they're not blind and they haven't been blind since birth”
(ID22, pharmacist, independent, HB-F)“I think the sight loss is the most challenging because they can't
read any labels and if someone tells you what to do by the time you
get home you have forgotten, so I imagine if I had polypharmacy
and it was all being done verbally it would be very, very confusing”
(ID2, pharmacist, small multiple, HB-A)
Interviewees identiﬁed that patients with sight impairment
often needed help in signing the prescription (a legal requirement
in Scotland to prevent fraud) and those with hearing impairment
may not hear their names called in the pharmacy when their pre-
scription medicines were ready. Some respondents commented
that home delivery schemes (delivering prescription medicines to
the patient's address) meant that they had less direct, in-person
contact with patients, and thus missed opportunities for involve-
ment in their ongoing pharmaceutical care needs.
“These patients are now being cared for with delivery services and
things. So it's more the delivery driver who sees them on a week to
week and a month to month basis rather than the pharmacist,
which is a bit of shame” (ID1, Pharmacist, Supermarket, HB-A)
Most responses from interviewees addressed either hearing or
sight impairment; there was little mention of dual sensory
impairment. Interviewees tended to be unsure how to communi-
cate with patients with dual sensory impairment and when dual
impairment was identiﬁed, there was strong reliance on the carer
(if the patient had one).
“Usually the people like that [with dual impairment] would come in
with a carer or usually next of kin or wife, husband, anything like
that but I honestly don't know to be honest … Um-hum, which
obviously isn't the best way; ideally we would be providing the
information directly to him” (ID3, Pre-registration Pharmacist,
Small chain, HB-A)Factors affecting the provision of pharmaceutical care
Five factors were identiﬁed within this theme, which were
perceived to inﬂuence the pharmaceutical care of older patients
with sensory impairment: community pharmacy personnel's
awareness of the sensory impairment; community pharmacy per-
sonnel's perception of older people with sensory impairment;
relying on carer support; pharmacy layout and physical access and
organisational factors (Fig. 1).
Interviewees were not always aware of a patient's sensory
impairment. Where they were aware, the impairment was often
inferred from the presence of visual cues such as sensory aids (e.g.
hearing aids) or requests to speak up. Interviewees suggested that
people with sensory impairment ‘hid’ their impairment, com-
menting that this was possibly as means of maintaining their in-
dependence or avoiding feelings of embarrassment.
“Sometimes people are very good at hiding their impairment… you
do get halfway through a consultation and you realise that
someone's just been “kind of smiling and not saying anything …
there might be an element of embarrassment… to ask you to repeat
things or when they need that little extra help” (ID30, pre-
registration pharmacist, multiple chain, HB-E)
“Really good at hiding it and especially if it is really hectic. When
they are coming into an environment that they are very familiar
with they know howmany steps to take forward to the counter and
that the biro is on the left and they really can look like they are
managing very well” (ID5, Pharmacist, Independent, HB-A)
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personnel to be the main characteristic of this patient population.
There was uncertainty about whether patients would accept
additional assistance. Problems with medicines adherence were
attributed to patients “being stubborn” and not accepting assistance
offered. Other interviewees suggested that due to sensory impair-
ment, patients were probably fearful of taking the wrong medicine
at the wrong time, not understanding their medicines, fearing
overdose and side effects alongside depression, loss of control and
lack of conﬁdence.
“She's so feisty and so independent, you know if you looked at her
medical record, you'd think ‘how is she living?’ Independently, she's
clearly found ways to deal with it and to be extremely independent,
and we have a role to help keep her living as independently as she'd
like to be” (ID15, pharmacist, independent, HB-G)
Some interviewees assumed that older people usually have
carers helping them in their everyday activities, and that this
included managing their medicines. Other interviewees discussed
that when the carer was the spouse, they might also have sensory
impairment or other conditions such as dementia, or may have died
leaving the person with sensory impairment living alone. When
formal carers were present, there were variations in services
offered by different agencies.
“Most of these patients would have some support that would take
on that role and we could do that via a third party. I can't think of
any instance where we have an isolated patient that would have no
help in that situation, so it hasn't proved to be a problem for us… I
mean carers of some kind to help them with any medication, pol-
ypharmacy” (ID2, pharmacist, small multiple, HB-A)
Other factors included organisational and environmental
(pharmacy layout) problems such as noise levels in the pharmacy
which affects hearing, and problems with pharmacy lighting and
signage, social stigma around hearing impairment, lack of access to
patient records, time constraints e since this patient group needed
more time to ensure good consultations, workload, insufﬁcient
stafﬁng, role delegation in the pharmacy and compliance with
regulations.
“the background noise can be a problem in the pharmacy. I ﬁnd it
difﬁcult tohear sometimes,” (ID12,pharmacist, independent,HB-H)
“So we've tried to make the environment great for, or better,
because community pharmacies are traditionally pretty poor in
terms of lighting and signage and things. And that involves getting
the person through the door. So I think if somebody comes through
the door, then we have lots of tools available” (ID15, pharmacist,
independent, HB-G)
“[Pharmacy] companies are taking away staff or not replacing staff
when they leave. So therefore, everyone becomesmore stretched and
everyone has to do more with that same amount of time. Therefore,
you don't have the same amount of time to spend with customers or
your patients” (ID1, pharmacist, supermarket, HB-A)
Solutions
Participants in the study suggested generic and focussed solu-
tions for improving pharmaceutical care that included raising
awareness of the difﬁculties faced by patients with sensory
impairment as a result of communications and environmental
barriers and good examples of practice where the pharmaceuticalcare needs of this patient population had been met. Most in-
terviewees discussed training needs in relation to providing
appropriate pharmaceutical care for this patient population. A
range of training needs was identiﬁed for pharmacists as well as
other pharmacy personnel - counter assistants, technicians and
drivers e and included: skills in identifying people with sensory
impairment; enhanced communication techniques, for example,
interpersonal skills on how to approach someone with a sensory
impairment without patronising them; training in sign language;
and use of sensory aids such as hearing loops.
“It [training course] opened my eyes to some things. I just assumed,
I think like a lot of people, that deaf people are just able to read. I
was really shocked that a lot of them can't. The other thing is that
BSL [British Sign Language] is completely different. I just thought
it'd be our spoken language translated visually but the fact is that
it’s a completely different language really. I thought as well hearing
aids and the implant … I thought that just ﬁxed your hearing”
(ID19, Trainee Technician, Small chain, HB-I)
Some interviewees described speciﬁc approaches to help with
providing pharmaceutical care for older people with sensory
impairment, including: simplifying complex dosing schemes;
counselling at home; notes on sensory needs in patient ﬁles;
medicines administration records chart; consulting the patient
about what could help them and providing hearing tests in the
pharmacy. One participant also suggested having a referral system
to specialist pharmacists trained to communicate with people with
hearing or sight impairment.
“We have one patient with sight loss who can't see at all so what we
actually do for that patient is we have an arrangement with her
that she gets tablets she takes in the morning and tablets she takes
at night. We deliver to this patient because she ﬁnds it difﬁcult to
get [here] because she can't see and she lives in the countryside”
(ID20, pharmacist, independent, HB-H)
“I went out and did a house visit to an elderly gentleman who is
struggling with his medicine. He was fairly, in fact almost
completely deaf … and was being aided by his carer, but the carer
was concerned when she wasn't there because he was an elderly
gentleman living by himself. He was taking extra tablets and things
like that. So we decided to do a full review and the upshot of it was
he ended up getting a [multi-compartment compliance aid] but we
had to ascertain what he had taken, what time suited him and
things like that” (ID21, pharmacist, independent, HB-D)Discussion
This study has highlighted the experiences and perspectives of
community pharmacy personnel in relation to providing pharma-
ceutical care for older people with sensory impairment and poly-
pharmacy. Of importance (and concern) is that interviewees
reported that these patients do not tend to disclose their sensory
impairment to community pharmacy personnel and the latter
seldom have systems for identifying people with these types of
impairment. The results indicate a need to train pharmacy
personnel to: recognise sensory impairments; understand
disability etiquette and communication skills in interacting with
older people with sensory impairments; raise awareness of the
challenges encountered by this patient population; use sign lan-
guage and/or sensory aids such as hearing loops and other inno-
vative technologies; and, how to best manage medication for older
people with sensory impairment.
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do not report medication side effects to their pharmacists37 and
that individuals with sight impairment do not tell their healthcare
professionals about their difﬁculties with their medicines.38 Non-
disclosure, or failure to identify the sensory impairment, means
that the pharmaceutical care provided is unlikely to reﬂect indi-
vidual patient's needs in addition to increasing risk with medica-
tion safety. This problem is further compounded by the lack of
direct contact with community pharmacy personnel on pharmacy
premises due to the increasing use of delivery services.
Some problems identiﬁed are common across people with
sensory impairment irrespective of age. Others, however, are
unique to older individuals who are more likely to receive poly-
pharmacy (the focus of this study), such as: the use of multi-
compartment compliance aids and delivery services; dropping
tablets on the ﬂoor due to packaging problems and motor disor-
ders; inability to retain information due to memory loss; pharmacy
personnel's perception of older people as stubborn; and the
inability of older people to use sign language or Braille. There is also
a concern that older people with sensory impairment are more
likely to develop Alzheimer's disease or dementia, compared with
those unaffected by these conditions.39 This adds to the problem of
managing medicines in this patient population.
To tackle these challenges, Health and Social Services and older
people with sensory impairment could be consulted to develop
strategies to develop approaches for supportive disclosure of pa-
tients' sensory impairment to health care professionals in general,
including community pharmacy personnel. For example ‘SEE
HEAR’, a strategic framework for meeting the needs of people with
a sensory impairment in Scotland,40 recommends: “the introduction
of basic sensory checks for people of a certain age, and at agreed times
in their care pathway”; the provision of training programs for
frontline staff to increase their awareness of sensory impairments;
and sharing information between agencies in relation to people
who have received a diagnosis of a sensory impairment at any time
from birth onwards.
In this study, methods that were used to support older people
with sensory impairment in community pharmacy included
writing instructions, sign language, Braille and large print.
Although considered beneﬁcial, these methods were of limited
value for some individuals as demonstrated by the examples above.
Similarly, in a study of the communication of patients with altered
hearing ability, patients struggled with the complexity of written
information given to them.37 This earlier study suggest that if
written instructions are provided, the patient's reading ability
should be accommodated and their comprehension of the infor-
mation assessed, for example, by using Teach Back (when the
health professional asks the patient to feedback what they under-
stood from the information given to them).41
The European Commission issued general guidelines to improve
the readability of medical product labelling.42 These recommen-
dations include the use of Braille, font size: Sans serif typefaces,
16e20 point for text and/or in a format perceptible by hearing for
the blind and partially sighted patients. The use of 22 point Arial
signiﬁcantly improved the comprehension and adherence of pa-
tients with visual acuity less than 6/18.43 However, most pre-
scription directions are currently printed in font sizes two to three
times smaller than this.43 In the UK, the Design for Patient Safety
series44 considered “how better design can reduce risk, improve the
working environment, and ensure better, patient-centred care”. Their
guidelines included recommendations about packaging design,
labelling, the design of the dispensing environment and the graphic
design of medication packaging. Other guidelines have recently
(after the interviews in this study were conducted) been produced
in the UK for pharmacy staff regarding how to support patientswith sight impairment in pharmacy.45 All the above recommen-
dations and guidelines could be adopted by pharmaceutical com-
panies and pharmacies to address the safety problems caused by
current difﬁculties in communication with this patient group, in
particular packaging and the dispensing environment.
This study revealed that most interviewees addressed either
hearing or sight impairment; there was little mention of dual
sensory impairment. This points to the need for improving guide-
lines and resources for community pharmacy personnel to help
people with a dual sensory impairment. Most recently, a group of
international experts identiﬁed eight future research priorities to
optimise geriatric pharmacotherapy,46 which highlighted vulner-
able patient groups, polypharmacy and person-centred practices.
There is a need for the development of evidence-based strate-
gies to support older people with sensory impairment managing
their medicines safely and effectively. Pharmacy curricula in un-
dergraduate and post-graduate training programmes require re-
view to ensure that the training needs identiﬁed in this study are
addressed. Strategies to improve medication adherence of older
people include the use of personal systems, regular medication
review and community-driven support systems and medical ad-
vocates.47 It also follows that taking the aforementioned steps will
also have positive impact on the pharmaceutical care the wider
population living sensory impairment.
Study limitations and strengths
The study generated rich data and a range of perspectives by
interviewing different members of the pharmacy team and not
solely pharmacists. Whilst data collection was only conducted to
Scotland, it is likely that the ﬁndings will be of relevance to com-
munity pharmacy personnel elsewhere, due to the nature of the
topic under investigation. Due to time constraints arising mainly
from an extended period of recruitment, the interviewees were not
asked to review or comment on their transcripts or the ﬁndings.
Conclusion
Despite the growing prevalence of sensory impairment due to
the ageing population, this is the ﬁrst comprehensive exploration of
community pharmacy personnel's perspectives and experiences of
providing pharmaceutical care to older people with sensory
impairment. It is also one of the ﬁrst studies to consider intersec-
tional challenges in the development of support guidelines that are
not single condition-focused in the pharmaceutical management of
older people. Whilst many challenges were identiﬁed, a number of
potential solutions were also suggested. Strategies which
encourage sensory impairment disclosure or identiﬁcation need to
be established. The unmet training and educational needs of
community pharmacy personnel, as well as the need for techno-
logical innovations, warrant attention to optimise the provision of
pharmaceutical care to this patient population.
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